Dual-Phase Antibacterial and Anti-inflammatory Self-Locking Microarray Patches for the Effective Treatment of Acne Vulgaris
ACS Applied Materials & Interfaces · 2025-08-13 · 17 (32) · 45438-45447
DOI: 10.1021/acsami.5c07718 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published online on 2025-07-31. Written by Jisook Park and 3 co-authors. Institution: Cursus Bio Inc., Icure Tower, Gangnam-gu, Seoul 06170, Republic of Korea. Major MEDLINE topics: Acne Vulgaris, Anti-Bacterial Agents, Anti-Inflammatory Agents, Transdermal Patch. Cited 3 times so far (Crossref); 40 references. Funded by: Korea Technology and Information Promotion Agency for SMEs, Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Ko….
Abstract (original language)
Acne vulgaris is one of the most prevalent dermatological disorders, affecting approximately 85% of adolescents and often leading to permanent scarring, as well as psychological distress, if not effectively managed. Conventional acne therapies often prove inadequate due to limited skin penetration, the development of antibiotic resistance, and insufficient anti-inflammatory effects. To address this, we introduce a novel dual-phase self-locking microarray patch for an enhanced acne treatment. This dissolving microarray patch is engineered to provide sequential therapy: an initial phase releasing an antibacterial agent (to rapidly minimize Cutibacterium acnes) followed by a second phase delivering an anti-inflammatory agent (to mitigate local inflammation). The microarray also features a mechanical interlocking design that secures the patch to the skin for effective adhesion and drug release. Our clinical trials of the dual-phase self-locking microarray demonstrated an 81.4% reduction in acne lesions within 3 days, with complete clearance by day 7. In addition, sebum secretion was reduced by 40.7%, suggesting the therapeutic effectiveness of self-locking microarrays. Findings of this study suggest the potential of self-locking microarrays as a safe and effective transdermal drug-delivery platform for clinical applications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Cursus Bio Inc., Icure Tower, Gangnam-gu, Seoul 06170, Republic of Korea.
- Department of Bioengineering, Institute for Bioengineering and Biopharmaceutical Research, Hanyang University, Seongdong-gu, Seoul 04763, Republic of Korea.
ORCID profiles: Yong-Hee Kim
Funding
- Korea Technology and Information Promotion Agency for SMEs
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Ko…
Cite
APA
Park, J., Kim, J., Fakhraei Lahiji, S., & Kim, Y. H. (2025). Dual-Phase Antibacterial and Anti-inflammatory Self-Locking Microarray Patches for the Effective Treatment of Acne Vulgaris. ACS Applied Materials & Interfaces, 17(32), 45438-45447. https://doi.org/10.1021/acsami.5c07718
Vancouver
Park J, Kim J, Fakhraei Lahiji S, Kim YH. Dual-Phase Antibacterial and Anti-inflammatory Self-Locking Microarray Patches for the Effective Treatment of Acne Vulgaris. ACS Applied Materials & Interfaces. 2025;17(32):45438-45447. doi:10.1021/acsami.5c07718
BibTeX
@article{Park2025,
author = {Park, Jisook and Kim, Jaehyun and Fakhraei Lahiji, Shayan and Kim, Yong-Hee},
title = {Dual-Phase Antibacterial and Anti-inflammatory Self-Locking Microarray Patches for the Effective Treatment of Acne Vulgaris},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {32},
pages = {45438--45447},
doi = {10.1021/acsami.5c07718}
}
EUVIMED